A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding

Abstract Snake envenomation is an important medical problem. One of the hurdles in antivenom development is the in vivo assay of antivenom potency which is expensive, gives variable results and kills many animals. We report a novel in vitro assay involving the specific binding of the postsynaptic ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kavi Ratanabanangkoon, Pavinee Simsiriwong, Kritsada Pruksaphon, Kae Yi Tan, Sukanya Eursakun, Choo Hock Tan, Bunkuea Chantrathonkul, Wongsakorn Wongwadhunyoo, Sirida Youngchim, Nget Hong Tan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c37c2be9b26744c9a2ac701ad38d5c98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c37c2be9b26744c9a2ac701ad38d5c98
record_format dspace
spelling oai:doaj.org-article:c37c2be9b26744c9a2ac701ad38d5c982021-12-02T15:04:51ZA novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding10.1038/s41598-017-08962-32045-2322https://doaj.org/article/c37c2be9b26744c9a2ac701ad38d5c982017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08962-3https://doaj.org/toc/2045-2322Abstract Snake envenomation is an important medical problem. One of the hurdles in antivenom development is the in vivo assay of antivenom potency which is expensive, gives variable results and kills many animals. We report a novel in vitro assay involving the specific binding of the postsynaptic neurotoxins (PSNTs) of elapid snakes with purified Torpedo californica nicotinic acetylcholine receptor (nAChR). The potency of an antivenom is determined by its antibody ability to bind and neutralize the PSNT, thus preventing it from binding to nAChR. The PSNT of Naja kaouthia (NK3) was immobilized on microtiter wells and nAChR was added to bind with it. The in vitro IC50 of N. kaouthia venom that inhibited 50% of nAChR binding to the immobilized NK3 was determined. Varying concentrations of antisera against N. kaouthia were separately pre-incubated with 5xIC50 of N. kaouthia venom. The remaining free NK3 were incubated with nAChR before adding to the NK3 coated plates. The in vitro and in vivo median effective ratio, ER50s of 12 batches of antisera showed correlation (R 2) of 0.9809 (p < 0.0001). This in vitro assay should be applicable to antisera against other elapid venoms and should reduce the use of live animals and accelerate development of life-saving antivenoms.Kavi RatanabanangkoonPavinee SimsiriwongKritsada PruksaphonKae Yi TanSukanya EursakunChoo Hock TanBunkuea ChantrathonkulWongsakorn WongwadhunyooSirida YoungchimNget Hong TanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kavi Ratanabanangkoon
Pavinee Simsiriwong
Kritsada Pruksaphon
Kae Yi Tan
Sukanya Eursakun
Choo Hock Tan
Bunkuea Chantrathonkul
Wongsakorn Wongwadhunyoo
Sirida Youngchim
Nget Hong Tan
A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
description Abstract Snake envenomation is an important medical problem. One of the hurdles in antivenom development is the in vivo assay of antivenom potency which is expensive, gives variable results and kills many animals. We report a novel in vitro assay involving the specific binding of the postsynaptic neurotoxins (PSNTs) of elapid snakes with purified Torpedo californica nicotinic acetylcholine receptor (nAChR). The potency of an antivenom is determined by its antibody ability to bind and neutralize the PSNT, thus preventing it from binding to nAChR. The PSNT of Naja kaouthia (NK3) was immobilized on microtiter wells and nAChR was added to bind with it. The in vitro IC50 of N. kaouthia venom that inhibited 50% of nAChR binding to the immobilized NK3 was determined. Varying concentrations of antisera against N. kaouthia were separately pre-incubated with 5xIC50 of N. kaouthia venom. The remaining free NK3 were incubated with nAChR before adding to the NK3 coated plates. The in vitro and in vivo median effective ratio, ER50s of 12 batches of antisera showed correlation (R 2) of 0.9809 (p < 0.0001). This in vitro assay should be applicable to antisera against other elapid venoms and should reduce the use of live animals and accelerate development of life-saving antivenoms.
format article
author Kavi Ratanabanangkoon
Pavinee Simsiriwong
Kritsada Pruksaphon
Kae Yi Tan
Sukanya Eursakun
Choo Hock Tan
Bunkuea Chantrathonkul
Wongsakorn Wongwadhunyoo
Sirida Youngchim
Nget Hong Tan
author_facet Kavi Ratanabanangkoon
Pavinee Simsiriwong
Kritsada Pruksaphon
Kae Yi Tan
Sukanya Eursakun
Choo Hock Tan
Bunkuea Chantrathonkul
Wongsakorn Wongwadhunyoo
Sirida Youngchim
Nget Hong Tan
author_sort Kavi Ratanabanangkoon
title A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
title_short A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
title_full A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
title_fullStr A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
title_full_unstemmed A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
title_sort novel in vitro potency assay of antisera against thai naja kaouthia based on nicotinic acetylcholine receptor binding
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c37c2be9b26744c9a2ac701ad38d5c98
work_keys_str_mv AT kaviratanabanangkoon anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT pavineesimsiriwong anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT kritsadapruksaphon anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT kaeyitan anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT sukanyaeursakun anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT choohocktan anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT bunkueachantrathonkul anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT wongsakornwongwadhunyoo anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT siridayoungchim anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT ngethongtan anovelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT kaviratanabanangkoon novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT pavineesimsiriwong novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT kritsadapruksaphon novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT kaeyitan novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT sukanyaeursakun novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT choohocktan novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT bunkueachantrathonkul novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT wongsakornwongwadhunyoo novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT siridayoungchim novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
AT ngethongtan novelinvitropotencyassayofantiseraagainstthainajakaouthiabasedonnicotinicacetylcholinereceptorbinding
_version_ 1718389040821043200